Literature DB >> 1338669

[The possibilities of using the free polyamines of the peripheral blood as biochemical tumor markers in nephroblastoma in children].

O V Balitskaia, N K Berdinskikh, N G Kononenko.   

Abstract

Thin-layer chromatography was used to measure free polyamine level in blood plasma and peripheral blood cells in 38 pediatric nephroblastoma patients and 30 apparently healthy children. Thirty-six nephroblastoma patients were examined in the course of treatment of whom 25-during 1-36 months following basic treatment course as well. A significant increase in the initial free polyamine level in blood cells (92.4% of cases) and plasma (63%) of nephroblastoma patients was observed. A correlation was established between changes in free polyamine level, on the one hand, and response to treatment and subsequent course of disease, on the other. At 8-10 days following radical surgery, a decrease in polyamine level was observed in 58% of operated cases and an increase-in 41.8%. The latter proved prognostically unfavorable. Recurrence and metastases development was associated with a rise in polyamine concentration in plasma and, particularly, in blood cells which in some cases preceded the appearance of other signs of tumor progression. The polyamine test can be recommended for monitoring pediatric nephroblastoma patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338669

Source DB:  PubMed          Journal:  Vopr Onkol        ISSN: 0507-3758


  2 in total

1.  Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.

Authors:  Karin M Kirschner; Julian F W Braun; Charlotte L Jacobi; Lucas J Rudigier; Anja Bondke Persson; Holger Scholz
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

2.  Serum tumor markers in pediatric osteosarcoma: a summary review.

Authors:  Yulia A Savitskaya; Genaro Rico-Martínez; Luis Miguel Linares-González; Ernesto Andrés Delgado-Cedillo; René Téllez-Gastelum; Alfonso Benito Alfaro-Rodríguez; Antonio Redón-Tavera; José Clemente Ibarra-Ponce de León
Journal:  Clin Sarcoma Res       Date:  2012-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.